You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

nilotinib

Showing 26 - 50 of 252
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Flumatinib Versus Nilotinib for Chronic Phase Chronic Myeloid

Recruiting
  • CML-CP; Mutation;Suboptimal Response or Failure in TKI
  • Wuhan, Hubei, China
    Weiming Li
May 31, 2021

Imatinib-resistant/Intolerant Chronic Myeloid Leukemia Treated

Completed
  • Chronic Myeloid Leukaemia
  • Rionero in Vulture, Potenza, Italy
  • +32 more
Oct 24, 2022

Healthy Trial (Nilotinib)

Completed
  • Healthy
  • Nilotinib
  • (no location specified)
Dec 6, 2020

Chronic Myeloid Leukemia Trial in Italy (Nilotinib)

Completed
  • Chronic Myeloid Leukemia
  • Nilotinib
  • Ascoli Piceno, Italy
  • +21 more
Jan 3, 2022

Chronic GVHD Trial in Israel, Italy (nilotinib)

Completed
  • Chronic Graft Versus Host Disease
  • nilotinib
  • Tel Hashomer, Israel
  • +11 more
Aug 19, 2021

Nilotinib for Chronic Myeloid Leukemia in First Line and Any

Completed
  • Chronic Myeloid Leukemia
  • Nilotinib
  • Freudenstadt, Baden Wuerttemberg, Germany
  • +76 more
Feb 9, 2023

CML, Philadelphia Chromosome Positive (Ph+), Chronic Myelogenous Leukemia Chronic Phase(CML-CP) Patients With Low Imatinib

Terminated
Has Results
  • CML
  • +2 more
  • nilotinib
  • Las Vegas, Nevada
  • +2 more
Apr 28, 2021

Chronic Myeloid Leukemia, Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission, Chronic Myeloid Leukemia in Remission Trial

Recruiting
  • Chronic Myeloid Leukemia
  • +2 more
  • Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Withdrawal
  • Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Re-initiation
  • Houston, Texas
  • +3 more
Jan 25, 2022

Chronic Myeloid Leukemia Trial in Germany (Nilotinib)

Completed
Has Results
  • Chronic Myeloid Leukemia
  • Nilotinib
  • Mannheim, Baden-Wuerttemberg, Germany
  • +69 more
Mar 21, 2022

Tyrosine Kinase Inhibitors on Liver Enzymes and Electrolytes

Active, not recruiting
  • Patients Diagnosed as Chronic Meyloid Leukemia
  • Tyrosine kinase Inhibitors (Imatinib & Nilotinib)
  • Assiut, Egypt
    Assiut University Hospital
Feb 19, 2022

Flumatinib Versus Nilotinib for Newly Diagnosed Chronic Phase

Recruiting
  • CML, Chronic Phase; TKI
  • Flumatinib Mesylate
  • Nilotinib Pill
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University, Jiangsu Ins
Feb 1, 2021

TyrosIne Kinase Inhibitors in Chronic Myeloid Leukemia: Efficacy

Recruiting
  • Chronic Myeloid Leukemia
  • Pisa, Italy
  • +1 more
Jan 4, 2022

Leukemia, Chronic Myeloid Trial in Ann Arbor, Winston-Salem (Nilotinib, Ruxolitinib)

Withdrawn
  • Leukemia, Chronic Myeloid
  • Ann Arbor, Michigan
  • +1 more
Feb 11, 2021

Chronic Phase Chronic Myeloid Leukemia Trial in Tampa (Nilotinib, Ruxolitinib)

Completed
  • Chronic Phase Chronic Myeloid Leukemia
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 4, 2021

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +19 more
  • Nilotinib
  • +4 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Mar 19, 2021

Leukemia Trial in Italy (drug, genetic, other)

Completed
  • Leukemia
  • imatinib mesylate
  • +8 more
  • Rionero in Vulture, Potenza, Italy
  • +36 more
Jan 3, 2022

Chronic Myelogenous Leukemia - Chronic Phase Trial in United States (Nilotinib)

Terminated
Has Results
  • Chronic Myelogenous Leukemia - Chronic Phase
  • Nilotinib
  • Los Angeles, California
  • +10 more
Jul 26, 2021

Healthy Trial in Seoul (Metformin, Metformin + Nilotinib)

Completed
  • Healthy
  • Seoul, Guro-gu, Korea, Republic of
    Korea University Guro Hospital
Nov 3, 2020

Malignant Solid Tumors Trial in France (Nilotinib (400 mg BID), Everolimus (10 mg QD), Sorafenib (400 mg BID))

Recruiting
  • Malignant Solid Neoplasms
  • Nilotinib (400 mg BID)
  • +6 more
  • Bordeaux, France
  • +6 more
Dec 15, 2022

CML, Chronic Myelogenous Leukemia, Leukemia, Myeloid Chronic Trial in Worldwide (Asciminib add-on, Imatinib, Nilotinib)

Recruiting
  • CML
  • +3 more
  • Asciminib add-on
  • +3 more
  • Augusta, Georgia
  • +46 more
Jan 23, 2023

Chronic Myeloid Leukemia Trial in Worldwide (nilotinib)

Active, not recruiting
Has Results
  • Chronic Myeloid Leukemia
  • nilotinib
  • Los Angeles, California
  • +61 more
Mar 17, 2022

Chronic Myelogenous Leukemia Trial in Canada, United States (Nilotinib)

Completed
Has Results
  • Chronic Myelogenous Leukemia
  • Nilotinib
  • Fayetteville, Arkansas
  • +22 more
Jun 29, 2021

Leukemia, Myeloid, Chronic-Phase Trial in Italy (Nilotinib 300mg BID)

Completed
  • Leukemia, Myeloid, Chronic-Phase
  • Nilotinib 300mg BID
  • Gallarate, Milano, Italy
  • +16 more
Jan 11, 2021

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Aichi (Nilotinib)

Completed
  • Chronic Myelogenous Leukemia
  • Acute Lymphoblastic Leukemia
  • Nilotinib
  • Aichi, Japan
    Novartis Investigative Site
Dec 6, 2020

Chronic Myeloid Leukemia, Chronic Phase, Withdrawal;Drug Trial in Czechia (Imatinib withdrawal, Dasatinib, Nilotinib)

Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • Withdrawal;Drug
  • Imatinib withdrawal
  • +2 more
  • Brno, Czechia
  • +7 more
Aug 24, 2022